Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
By
MedTech Outlook | Wednesday, November 11, 2026
Medical device procurement in stoma care becomes difficult when standardisation collides with individual fit. A pouching system may perform consistently in production yet still prove unsuitable when body contours change, or skin becomes irritated. Wear time can also shift as a person’s condition changes. That makes product range and material choice central to evaluation. Buyers should look beyond a manufacturer’s core format and examine whether its portfolio can accommodate different skin conditions and adhesion preferences without forcing clinicians toward workarounds.
Skin protection deserves particular scrutiny because adhesive behaviour affects both wear and patient comfort. Hydrocolloid barriers remain familiar across ostomy care, but material choice should be assessed by how it manages moisture and how gently it releases from the skin. Siliconebased barriers introduce another route, especially where breathability and movement with the body matter. The relevant question is not whether one material replaces another. It is whether the manufacturer offers distinct technologies with clearly different use cases, giving clinicians room to match a product to the person rather than treating one construction as universal.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Buyers also need enough choice within each material family to respond when a previously suitable pouch no longer performs as expected. Procurement teams should also examine whether accessory dependence increases when fit problems emerge, since repeated additions can complicate patient routines and make the underlying pouching system harder to assess consistently.
Manufacturing discipline is equally important because product consistency has direct consequences once a device reaches routine use. Buyers should examine where production takes place and how quality assurance is embedded in manufacturing. They should also consider how easily a supplier can maintain standards across larger and smaller production runs. Flexibility at the factory level matters when a portfolio includes both high-volume products and more specialised configurations.
“The stronger model is one in which those signals reach product development without displacing the manufacturing controls needed for dependable supply.”
A manufacturer that can shift production without making smaller-volume items uneconomical is better placed to support a wider range of patient requirements. That flexibility should not come at the expense of repeatable adhesion and barrier performance from one batch to the next.
Portfolio breadth should also be judged by how product development is informed. Direct feedback from people living with a stoma can expose problems that distributor data or procurement history may not show, particularly around comfort and changing fit. Input from clinicians adds another layer because it reflects repeated exposure to product performance across different patients.
Distributors can reveal recurring supply or configuration demands that may otherwise remain fragmented. The stronger model is one in which those signals reach product development without displacing the manufacturing controls needed for dependable supply. Environmental considerations also belong in that discussion, particularly where a supplier can reduce manufacturing waste while preserving the reliability required of disposable medical devices.
Unora manufactures its ostomy products in Berlin and combines long-standing production experience with a portfolio spanning silicone barriers and hydrocolloid-based options, including alginate-infused products. Its Silkura line uses a silicone flange designed to balance adhesion with flexibility while allowing moisture to pass through the barrier. Unora also offers alginate-infused hydrocolloid products intended for users dealing with skin irritation.
Its manufacturing model supports different production volumes, while its direct-to-consumer programs in the UK and Germany feed user experience back into product development. For buyers comparing stoma care manufacturers, Unora merits consideration where production consistency matters and material choice is informed by closer product-user feedback.
More in News
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
